Subendothelial retention of atherogenic lipoproteins in early atherosclerosis
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Complications of atherosclerosis are the most common cause of death in Western societies. Among the many risk factors identified by epidemiological studies, only elevated levels of lipoproteins containing apolipoprotein (apo) B can drive the development of atherosclerosis in humans and experimental animals even in the absence of other risk factors. However, the mechanisms that lead to atherosclerosis are still poorly understood. We tested the hypothesis that the subendothelial retention of atherogenic apoB-containing lipoproteins is the initiating event in atherogenesis. The extracellular matrix of the subendothelium, particularly proteoglycans, is thought to play a major role in the retention of atherogenic lipoproteins. The interaction between atherogenic lipoproteins and proteoglycans involves an ionic interaction between basic amino acids in apoB100 and negatively charged sulphate groups on the proteoglycans. Here we present direct experimental evidence that the atherogenicity of apoB-containing low-density lipoproteins (LDL) is linked to their affinity for artery wall proteoglycans. Mice expressing proteoglycan-binding-defective LDL developed significantly less atherosclerosis than mice expressing wild-type control LDL. We conclude that subendothelial retention of apoB100-containing lipoprotein is an early step in atherogenesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Elevated concentration of low-density lipoprotein enhances its retention under the arterial wall(17); retention and oxidation of low-density lipoprotein are fundamental events in atherogenesis.(18)”
From Endometriosis and Risk of Coronary Heart Disease (2016) · cites this paper as [18]
In the citing paper
“The ECM has a central role in initiation of atherosclerosis, primarily through the interaction between the negatively charged side chains of proteoglycans (particularly chondroitin sulphate of biglycan and versican and heparin sulphate of perlecan 110 ) with positively charged apolipoproteins (especially apolipoprotein B) , which leads to the retention of plasma-derived lipoproteins 101,111 - as”
From Vascular smooth muscle cells in atherosclerosis (2019) · cites this paper as [101]
In the citing paper
“the interaction of apoB-containing lipoproteins (the non-HDL lipoproteins) with intimal extracellular proteoglycans (referred to as retention)1,43,44 inhibits the movement of the lipoproteins, thereby resulting in much higher subendothelial concentrations of these lipoproteins in the intima than in any other tissue45.”
From Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities (2019) · cites this paper as [44]
Citations
Cites
A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751
Glass, C. K., & Witztum, J. L. (2001) · Cell · doi:10.1016/s0092-8674(01)00238-0 · Cited by 3,051
Efficient Trace-labelling of Proteins with Iodine
McFARLANE, A. S. (1958) · Nature · doi:10.1038/182053a0 · Cited by 2,543
A simple fluorometric assay for lipoperoxide in blood plasma
Yagi, K. (1976) · Biochemical Medicine · doi:10.1016/0006-2944(76)90049-1 · Cited by 2,103 · cited 1×
“The concentrations of thiobarbituric-acid-reactive substance”
The Response-to-Retention Hypothesis of Early Atherogenesis
Williams, K. J., & Tabas, I. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.5.551 · Cited by 1,413
Cell Biology of Atherosclerosis
Ross, R. (1995) · Annual Review of Physiology · doi:10.1146/annurev.ph.57.030195.004043 · Cited by 1,003 · cited 1×
“gif" NDATA ITEM> ]> Complications of atherosclerosis are the most common cause of death in Western societie”
BackgroundTangirala, R. K., Rubin, E. M., & Palinski, W. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39713-3 · Cited by 514
Mahley, R. W., Innerarity, T. L., Pitas, R. E., Weisgraber, K. H., Brown, J. H., & Gross, E. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)66966-8 · Cited by 383
Self-citationBorén, J., Olin, K., Lee, I., Chait, A., Wight, T. N., & Innerarity, T. L. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2265 · Cited by 320 · cited 1×
“The interaction between atherogenic lipoproteins and proteoglycans involves an ionic interaction between basic amino acids in apoB100 and negatively charged sulphate groups on the proteoglycan”
BackgroundSelf-citationImmunoglobulin treatment reduces atherosclerosis in apo E knockout mice.
Nicoletti, A., Kaveri, S., Caligiuri, G., Bariéty, J., & Hansson, G. K. (1998) · Journal of Clinical Investigation · doi:10.1172/jci119892 · Cited by 301
Cited by
Items 601–700 of 1,000
Sesorova, I. S., Sesorov, V. V., Soloviev, P. B., Lakunin, K. Y., Dimov, I. D., & Aa, M. (2022) · Biomedicines · doi:10.3390/biomedicines10112858 · Cited by 11
“Indeed, initially formed atherosclerotic plaques contained the neutral complex biantennary glycan, which is a ligand for a macrophage asialoglycoprotein receptor that is involved in foam cell formation [97].”
BackgroundAmssayef, A., Azzaoui, B. E., Ajebli, M., & Eddouks, M. (2020) · Cardiovascular & Hematological Agents in Medicinal Chemistry · doi:10.2174/1871525718666200506100139 · Cited by 13
Subclinical Vascular Damage: Current Insights and Future Potential
Mattioli, A. V., Coppi, F., Manenti, A., & Farinetti, A. (2021) · Vascular Health and Risk Management · doi:10.2147/vhrm.s242636 · Cited by 11
“Several immune cells have been identified within the atheroma including T cells, neutrophils, macrophages and mast cells, which show signs of activation and produce pro-inflammatory interleukins and cytokines.(7) Despite the clear link between inflammation and atherogenesis, the causal relationship remains uncertain.”
BackgroundBreaking Bruch's: How changes in Bruch's membrane influence retinal homeostasis
Clark, S. J., Curcio, C. A., Dick, A. D., Doyle, S., Edwards, M. M., Flores‐Bellver, M., Hass, D. T., Lennon, R., Toomey, C. B., & Rohrer, B. (2025) · Experimental Eye Research · doi:10.1016/j.exer.2025.110343 · Cited by 11
“Studies in atherosclerosis have shown that increased retention, rather than increased influx, of lipoproteins is the primary factor driving subendothelial retention (Chait and Wight, 2000; Schwenke and St. Clair, 1993; Skål ´ en et al., 2002; Tabas et al., 2007; Williams and Tabas, 1995).”
Xie, Y., Wu, Q., Jia, Y., Cheng, L., Tian, Y., Yang, X., Wang, W., Xu, W., Zhao, Z., & Wei, Y. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf878 · Cited by 16
Qin, Z., Liu, Q., Jiao, P., Geng, J., Liao, R., & Su, B. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.870169 · Cited by 10
“Moreover, cadmium exposure could stimulate lipid deposition in the carotid artery and aorta (46, 47).”
BackgroundCheng, W., Shu, M., Kuang, L., Bai, X., Jia, X., Zhao, Y., Lu, Y., Zhu, L., Wang, L., Zhu, Y., et al. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.123836 · Cited by 10
Prognostic Nutritional Index as a Novel Predictor of In-Stent Restenosis: A Retrospective Study
Balun, A., Akgümüş, A., Özbek, K., & Çetin, Z. G. (2023) · Medicina · doi:10.3390/medicina59040663 · Cited by 10
Shi, Y., Jiang, M., Zhang, Y., Diao, Y., Li, N., Liu, W., Qiu, Z., Qiu, Y., & Jia, A. (2023) · Molecules · doi:10.3390/molecules28135088 · Cited by 11
“Vascular oxidative stress is critical in retaining subendothelial LDL-C, which is oxidized within inflammatory macrophages, ultimately contributing to the accumulation of foam cells and the formation of atherosclerotic plaques [55].”
BackgroundPhysiopathologie de l’athérosclérose et marqueurs précoces
Paul, J., & Baudin, B. (2009) · Revue Francophone des Laboratoires · doi:10.1016/s1773-035x(09)70199-6 · Cited by 20
Brito, V., Mellal, K., Zoccal, K. F., Soto, Y., Ménard, L., Sarduy, R., Faccioli, L. H., Ong, H., Vázquez, A. M., & Marleau, S. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00782 · Cited by 11
“…B (apoB)containing lipoproteins through an electrostatic interaction with negatively charged glycosaminoglycan (GAG) side chains of proteoglycans is considered a key initiating step of atherogenesis (Williams and Tabas, 1995; Boren et al., 1998; Skalen et al., 2002; Tabas et al., 2007).”
BackgroundVasculoprotective properties of plasma lipoproteins from brown bears (Ursus arctos)
Pedrelli, M., Parini, P., Kindberg, J., Arnemo, J. M., Björkhem, I., Aasa, U., Westerståhl, M., Walentinsson, A., Pavanello, C., Turri, M., et al. (2021) · Journal of Lipid Research · doi:10.1016/j.jlr.2021.100065 · Cited by 10
“The binding of human apoB100 lipoproteins to arterial PGs is mediated by specific sequences rich in arginine and lysine that have been identified ex vivo and animal models (25, 26).”
BackgroundMolecular Imaging of Vulnerable Coronary Plaque with Radiolabeled Somatostatin Receptors (SSTR)
Anzola, L. K., Rivera, J. N., Ramírez, J. C., Signore, A., & Mut, F. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10235515 · Cited by 10
“Atherosclerosis is liable for the majority of hard events and is characterized by the accumulation of lipids, inflammatory cells, and connective tissue within the arterial wall [23].”
BackgroundPathogenesis of Atherosclerosis
Shah, P. K. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6705-2_21 · Cited by 11
Tovar, A. M. F., Pecly, I. M. D., Rangel, E. P., Melo-Filho, N. M., Mourão, P. A. S., & Leite, M. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.06.011 · Cited by 12
“D P R O O F 6 A.M.F. Tovar et al. / Atherosclerosis xxx (2006) xxx–xxx”
BackgroundEffects of Oxidation on Structural Stability and Remodeling of Human Very Low Density Lipoprotein
Guha, M., & Gursky, O. (2010) · Biochemistry · doi:10.1021/bi101391z · Cited by 11
“At the same time, reduction in VLDL stability is expected to facilitate VLDL fusion, rupture and lipid droplet formation in the arterial wall, which is proatherogenic (7, 8).”
BackgroundMasson, W. M., Lobo, M., Siniawski, D. A., Molinero, G., Huerin, M. S., & Nogueira, J. P. (2019) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-019-00330-8 · Cited by 11
The antichlamydial effects of drugs used in cardiovascular diseases
Yan, Y. (2009) · Cited by 10
Recent research advances in metabolism, clinical and experimental
Boutari, C., Kokkorakis, M., Stefanakis, K., Valenzuela-Vallejo, L., Axarloglou, E., Volčanšek, Š., Chakhtoura, M., & Mantzoros, C. S. (2023) · Metabolism · doi:10.1016/j.metabol.2023.155722 · Cited by 9
Ferroptosis: A potential target of macrophages in plaque vulnerability
Li, Y., Ma, J., Wang, C.-C., Zhou, J., Sun, Y., Wei, X., & Zhao, Z. (2023) · Open Life Sciences · doi:10.1515/biol-2022-0722 · Cited by 10
“Macrophage death from recruitment due to pro-in fl ammatory factors [13], hypoxia from inadequate blood supply [14], and foam cell formation due to lipoprotein retention [15] are all hallmarks of advanced plaques.”
BackgroundAbdalla, H., Mahmoud, A., Khedr, A. E., Farina, J., Scalia, I. G., Abbas, M. T., Awad, K., Ali, N. B., Bismee, N. N., Esfahani, S. A., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252011029 · Cited by 10
“ApoB containing lipoproteins bind to proteoglycan-binding sites through ionic interactions, which is considered to be the key mechanism driving their retention and aggregation to the arterial wall [54].”
BackgroundToomey, C. B., Pflugmacher, S., Park, K., Pihl, J., Novak, S. W., Rodriguez, J. W., Jalali, M., Jung, J., Mozafari, M., Omran, S. P., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2500727122 · Cited by 11
“Studies in atherosclerosis have shown that increased retention, rather than increased influx, of lipoproteins is the primary factor driving subendothelial retention ( 26 , 27 ).”
Śmiłowska, K., Śmiłowski, M., Partyka, R., Kokocińska, D., & Jałowiecki, P. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12030457 · Cited by 9
“Atherosclerotic plaque lesions induce an inflammatory process, which is initiated by low density lipoprotein (LDL) molecules in the subendothelial area of arteries [21].”
BackgroundAtherogenesis, Transcytosis, and the Transmural Cholesterol Flux: A Critical Review
Goldberg, D., & Khatib, S. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/2253478 · Cited by 12
“The intima ’ s known ability to sequester cholesterol, which could maintain its concentration gradient, now facilitates its accumulation [66, 69, 83].”
Detection and Imaging of Active Substances in Early Atherosclerotic Lesions Using Fluorescent Probes
Li, J., Xu, J., Zhang, W., Li, P., Zhang, W., Wang, H., & Tang, B. (2023) · ChemBioChem · doi:10.1002/cbic.202300105 · Cited by 10
Wan, Q., Lu, Q., Luo, S., Guan, C., & Zhang, H. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03142-3 · Cited by 11
“…subsequent deposition of inflammatory cells such as macrophages, neutrophils, lymphocytes, and monocytes, as well as extracellular matrix (ECM) and neo-vasculature with intraplaque hemorrhage contributing to the formation of atherosclerotic plaques (Skalen et al. 2002; Soehnlein and Libby 2021).”
Proteoglycan–LDL interactions: A novel therapeutic target?
Tannock, L. R. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.12.049 · Cited by 12
“Murine studies using genetic models have demonstrated that expression of proteoglycan-binding-defective apoB100 attenuates development of atherosclerosis [8].”
BackgroundÖklü, R., Stone, J. R., Albadawi, H., & Watkins, M. T. (2014) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2013.12.567 · Cited by 10
Williams, K. J. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.06.023 · Cited by 9
The pathobiology of the vessel wall: Implications for imaging
Sadeghi, M. M. (2006) · Journal of Nuclear Cardiology · doi:10.1016/j.nuclcard.2006.03.012 · Cited by 10
D’Ulivo, L., Witos, J., Öörni, K., Kovanen, P. T., & Riekkola, M. (2010) · Analytica Chimica Acta · doi:10.1016/j.aca.2010.02.013 · Cited by 9
Schmitz, B., Salomon, A., Rötrige, A., Ritter, M., Ringelstein, E. B., Fischer, J. W., Paul, M., Brand, E., & Brand, S. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.301073 · Cited by 10
“Persistent low level of BGN in the ECM could prevent early atherosclerotic lesion development by reduced retention and oxidation of subendothelial low-density lipoprotein.(4) In turn, BGN is essential for controlled collagen deposition in the vasculature.”
BackgroundOxidative and Inflammatory Pathways in Age-Related Chronic Disease Processes
Campbell, A., & Solaimani, P. (2016) · Oxidative stress in applied basic research and clinical practice · doi:10.1007/978-3-319-33486-8_6 · Cited by 10
Ziaee, S., Boroumand, M. A., Salehi, R., Sadeghian, S., Hosseindokht, M., & Sharifi, M. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.09.134 · Cited by 9
Baber, U., Kini, A. S., Moreno, P., & Sharma, S. K. (2013) · Cardiology Clinics · doi:10.1016/j.ccl.2013.05.005 · Cited by 13
Guarino, A. J., Tulenko, T. N., & Wrenn, S. P. (2006) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2006.02.020 · Cited by 10
Obesity and Cardiovascular Disease
Poirier, P. (2006) · Circulation · doi:10.1161/circulationaha.106.646455 · Cited by 13
Tissue Factor, Its Pathway Inhibitor, and Metabolic Disturbances in Long-Term Peritoneal Dialysis
Zemanová, P., Opatrný, K., Jr., Opatrná, S., Vít, L., Šefrna, F., & Ráček, J. (2003) · Kidney & Blood Pressure Research · doi:10.1159/000073944 · Cited by 9
Niu, C., Zhang, P., Zhang, L., Lin, D., Lai, H., Xiao, D., Liu, Y., Zhuang, R., Li, M., Ma, L., et al. (2023) · Medicine · doi:10.1097/md.0000000000035106 · Cited by 9
“[31] The infiltration and retention of LDL in the arterial intima leads to inflammation in the arterial wall.[76] LDL is modified by oxidation or enzymatic attack in the intima, leading to the release of phospholipids, which can activate endothelial cells.”
BackgroundTargeting the adaptive immune continuum in atherosclerosis and post-MI injury
Juhász, V., Charlier, F., Zhao, T. X., & Tsiantoulas, D. (2024) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2024.118616 · Cited by 9
“ACVD occurs upon loss of tissue regulation in large and medium size arteries that is initiated by the retention of low-density lipoprotein (LDL) particles [5,6] and driven by immune cell infiltration in the subendothelial space [7].”
Zhang, C., Xie, Y., Zhou, J., Zhang, C., Xiang, Q., Zhong, Y., Xiao, J., Feng, J., Liao, B., Chen, X., et al. (2025) · Food Science & Nutrition · doi:10.1002/fsn3.70372 · Cited by 9
“…inflammation, endothelial dysfunction, dyslipidaemia, insulin resistance, environmental exposure, and pathogens, can influence the onset and progression of coronary atherosclerosis (Falk 2006), and dyslipidaemia is closely associated with it (Skålén et al. 2002; Bissell 2008; Catapano et al. 2016).”
Inflammation and coronary artery disease
Virmani, R., Kolodgie, F. D., BURKE, A. P., Farb, A. A., Gold, H. K., & Finn, A. V. (2003) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8047-3_3 · Cited by 8
Dystrophin deficiency reduces atherosclerotic plaque development in ApoE-null mice
Shami, A., Knutsson, A., Dunér, P., Rauch, U., Bengtsson, E., Tengryd, C., Murugesan, V., Durbeej, M., Gonçalves, I., Nilsson, J. Å., et al. (2015) · Scientific Reports · doi:10.1038/srep13904 · Cited by 9
Serglycin protects against high fat diet-induced increase in serum LDL in mice
Meen, A. J., Drevon, C. A., Pejler, G., Jenssen, T. G., Olstad, O. K., Åbrink, M., & Kolset, S. O. (2015) · Glycoconjugate Journal · doi:10.1007/s10719-015-9621-7 · Cited by 8
Wang, T., McElroy, A., Halaney, D. L., Vela, D. C., Fung, E., Hossain, S., Phipps, J. E., Wang, B., Yin, B., Feldman, M. D., et al. (2015) · Biomedical Optics Express · doi:10.1364/boe.6.001665 · Cited by 8
Wang, T., McElroy, A., Halaney, D. L., Vela, D. C., Fung, E., Hossain, S., Phipps, J. E., Wang, B., Yin, B., Feldman, M. D., et al. (2015) · Lasers in Surgery and Medicine · doi:10.1002/lsm.22366 · Cited by 9
“binding to lipid [11,12], a decrease in collagen synthe-”
BackgroundVCAM-1 and its functions in development and inflammatory diseases
Hyduk, S. J., & Cybulsky, M. I. (2007) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-7975-9_6 · Cited by 9
Promoting athero-protective immunity by vaccination with low density lipoprotein-derived antigens
Nilsson, J. Å., & Shah, P. K. (2021) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2021.08.033 · Cited by 8
Glise, L., Rutberg, M., Håversen, L., Levin, M. C., Levin, M., Jeppsson, A., Borén, J., & Fogelstrand, P. (2022) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.122.317868 · Cited by 8
Self-citationZhu, L., Xu, W., Chatterjee, E., Li, G., Wang, X., Xiao, J., Chen, X., & Yang, L. M. (2023) · Materials & Design · doi:10.1016/j.matdes.2023.112005 · Cited by 10
Hempseed water extract ameliorates atherosclerosis in apolipoprotein E knockout mice
Seo, J. H., Jeong, E.-S., Lee, K. S., Heo, S., Jeong, D. G., Lee, S., Kim, E. S., & Choi, Y. (2012) · Food Science and Biotechnology · doi:10.1007/s10068-012-0122-1 · Cited by 8
Effects of glycosaminoglycans in vascular events
Максименко, А. В. (2008) · Pharmaceutical Chemistry Journal · doi:10.1007/s11094-009-0188-0 · Cited by 9
Ke, Y., Xiao, W.-J., He, J., Zhang, H., Yu, J., Hu, W., Gu, J., Gao, G., Yue, H., Wang, C., et al. (2012) · Acta Pharmacologica Sinica · doi:10.1038/aps.2011.167 · Cited by 9
Cardiovascular consequences of obesity
Poirier, P., & Eckel, R. H. (2008) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2008.05.005 · Cited by 10
Ballinger, M. L., Osman, N., Wilks, A. F., Su, S. V., Burns, C. J., Bu, X., & Little, P. J. (2008) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e31818a8907 · Cited by 8
“The animal data in which modified lipoproteins that do not bind to proteoglycans result in greatly decreased atherosclerosis supports this hypothesis.(8) More recently, human pathology studies have demonstrated that the lipid accumulation occurs in the outer layer of diffuse intimal thickenings and is associated with…”
BackgroundLow density lipoprotein stimulation of human macrophage proteoglycan secretion
Lindholm, M., Nilsson, J. Å., & Moses, J. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.01.003 · Cited by 8
Comparison of apolipoprotein B and plasma lipids as targets for lipid lowering treatment
Vaverková, H., Frohlich, J. J., Jackuliaková, D., & Novotný, D. (2005) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2005.02.012 · Cited by 8
Vascular Dendritic Cells as Gatekeepers of Lipid Accumulation Within Nascent Atherosclerotic Plaques
Randolph, G. J., & Potteaux, S. (2010) · Circulation Research · doi:10.1161/circresaha.109.212191 · Cited by 8
Sreenivas Reddy, S., Raghavendra Rao, K., Kashyap, J. R., Kadiyala, V., Kumar, S., Dash, D., Uppal, L., Kaur, J., Kaur, M., Reddy, H., et al. (2024) · Indian Heart Journal · doi:10.1016/j.ihj.2024.10.004 · Cited by 7
Cardiomyocytes, sphingolipids and cardio myotoxicity
Levin, M. C., Andersson, L. K., & Borén, J. (2023) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000829 · Cited by 8
“Atherosclerosis is initiated by selective retention of atherogenic lipoproteins in the artery wall by binding to artery wall proteoglycans [41].”
BackgroundSelf-citationRonda, N., Zimetti, F., Adorni, M. P., Palumbo, M., Karpouzas, G. A., & Bernini, F. (2022) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2022.07.006 · Cited by 7
The Role of Inflammation in Myocardial Infarction
Daskalopoulos, E. P., Hermans, K. C. M., van Delft, L. C. J., Altara, R., & Blankesteijn, W. M. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-800039-7.00003-7 · Cited by 12
Size-selective uptake of colloidal low density lipoprotein aggregates by cultured white blood cells
Walters, M., & Wrenn, S. P. (2010) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2010.06.059 · Cited by 7
Thompson, J. C., Wilson, P. G., Wyllie, A. P., Wyllie, A. K., & Tannock, L. R. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.11.005 · Cited by 8
Nurtazina, A., Kozhakhmetova, D., Dautov, D., Khaidarova, N., & Chattu, V. K. (2021) · Diagnostics · doi:10.3390/diagnostics11050871 · Cited by 7
RGC-32′ dual role in smooth muscle cells and atherogenesis
Vlaicu, S. I., Tatomir, A., Fosbrink, M. D., Nguyen, V. Q., Boodhoo, D., Cudrici, C. D., Badea, T. C., Rus, V., & Rus, H. (2022) · Clinical Immunology · doi:10.1016/j.clim.2022.109020 · Cited by 7
Wu, M.-C., Ho, H.-I., Lee, T., Wu, H.-L., & Lo, J. (2012) · Journal of drug targeting · doi:10.3109/1061186x.2012.702768 · Cited by 7
“Consequently, an early phase of atherosclerosis is developed (Fenna et al., 1995; Fiedler et al., 2000; Lusis, 2000; de Winther & Hofker, 2000; Libby, 2002; Skålén et al., 2002; Shishehbor et al., 2003; Klebanoff, 2005; Nicholls & Hazen, 2005; Haas, 2007; Wang et al, 2007; Rader &”
BackgroundExtracellular Matrix and Smooth Muscle Cells
George, S. J., & Johnson, J. L. (2011) · Springer eBooks · doi:10.1007/978-3-7091-0338-8_22 · Cited by 8
Pathogenesis and treatment of diabetic vascular disease – illustrated by two cases
Smith, U., Laakso, M., Eliasson, B., Wesslau, C., Borén, J., Wiklund, O., & Attvall, S. (2006) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2006.01712.x · Cited by 10
Self-citationZhang, J., Xu, M., & Aronow, B. J. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02240-4 · Cited by 7
“Apolipoprotein B co-expresses with CIDE-B with high expression levels in the liver and GI tissues, suggesting that they may be involved in parallel biological processes in lipid metabolism [47,48].”
BackgroundSlowey, C., & Nyhan, D. P. (2022) · Anesthesiology Clinics · doi:10.1016/j.anclin.2022.08.004 · Cited by 7
Patti, G., Cavallari, I., Cesaro, A., Gragnano, F., Riva, L., Fimiani, F., Cuccia, C., Fresco, C., Calabrò, P., Leonardi, S., et al. (2022) · Vascular Pharmacology · doi:10.1016/j.vph.2022.107137 · Cited by 6
The Role of Scavenger Receptors in Signaling, Inflammation and Atherosclerosis
Sahoo, D., & Drover, V. A. B. (2006) · Springer eBooks · doi:10.1007/0-387-36279-3_5 · Cited by 8
“Lesion formation in the intimal space is thought to occur at sites of endothelial perturbation such as vessel injury, turbulent blood flow, and lipoprotein infiltration [ 1 ].”
BackgroundVuković, I., Lačković, V., Raičević, R., Lazić, Z., Milosavljević, Z., Kastratović, T., Mladenovic-Mihailovic, A., Stanković, V., & Lačković, M. (2010) · Vojnosanitetski pregled · doi:10.2298/vsp1012007v · Cited by 6
Mahmoudi, M., Siassi, F., Mahmoudi, M. J., Eshraghian, M. R., Zarnani, A., Rezaei, N., Hedayat, M., Shokri, F., & Saboor-Yaraghi, A.-A. (2010) · PubMed · Cited by 6
Suarez, E. C. (2012) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780195394399.013.0010 · Cited by 6
Schimke immunoosseous dysplasia and management considerations for vascular risks
Beleford, D. T., Diab, M., Qubty, W. F., Malloy, M. J., Long, R. K., & Shieh, J. T. C. (2019) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.61148 · Cited by 9
“Chronic kidney disease (CKD) is an independent risk factor for the development of cardiovascular disease, as are elevated levels of LDL-C and apo B100 (Fernandez-Friera et al., 2017; Sarnak et al., 2003; Skalen et al., 2002).”
BackgroundLi, W., Niu, X., Yu, J., Xiao, X., Zang, L., Zhao, J., Huang, Q., & Li, W. (2020) · Journal of Functional Foods · doi:10.1016/j.jff.2020.103982 · Cited by 6
ICAM-1: Contribution to Vascular Inflammation and Early Atherosclerosis
Sabine, I., & Lawso, C. (2012) · InTech eBooks · doi:10.5772/29608 · Cited by 8
Aggregation kinetics of low density lipoproteins upon exposure to sphingomyelinase
Guarino, A. J., Lee, S. P., Tulenko, T. N., & Wrenn, S. P. (2004) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2004.06.066 · Cited by 8
Celecoxib exhibits therapeutic potential in experimental model of hyperlipidaemia
Ekor, M., Agyei, P. E. O., Obese, E., Biney, R. P., Henneh, I. T., Antwi-Adjei, M., Yahaya, E. S., Amoakohene, G., & Akakpo, P. K. (2021) · PLoS ONE · doi:10.1371/journal.pone.0247735 · Cited by 5
“However, ample evidence suggests that pathological cause of reduced serum urea concentration is largely confined to severe liver disease [39,40].”
BackgroundChronic Coronary Artery Disease: Wall Disease vs. Lumenopathy
PARASKEVAIDIS, I. A., Kourek, C., & Tsougos, E. (2025) · Biomolecules · doi:10.3390/biom15020201 · Cited by 5
“The synthetic VSMC-derived ECM also captures plasma-derived lipoproteins, which undergo modification, such as LDL oxidation, triggering immune responses and amplifying inflammation [96].”
New Roles of Artemisinins in Atherosclerosis Progression
Majidiani, H., Musavi, M., & Momtazi‐Borojeni, A. A. (2025) · Phytotherapy Research · doi:10.1002/ptr.8483 · Cited by 8
“Moreover, lipases and proteases chemically modify these lipoprotein particles (Skålén et al. 2002; Williams and Tabas 1995), resulting in enhanced proteoglycan binding and aggregation (Pentikäinen et al. 2000).”
Dicks, L. M. T. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26189052 · Cited by 6
Vulnerable plaque: From bench to bedside; local pacification versus systemic therapy
Kasim, S. S., Moran, D., & McFadden, E. P. (2012) · Heart Views · doi:10.4103/1995-705x.105731 · Cited by 5
Wang, Y., Hammer, A., Höefler, G., Malle, E., Hawkins, C. L., Chuang, C. Y., & Davies, M. J. (2023) · Antioxidants · doi:10.3390/antiox12020420 · Cited by 6
Amaro, A. B., Garcia, E., Lhoëst, M. T. L. C., Martínez, A., Borràs, C., Tondo, M., Céspedes, M. V., Caruana, P., Pepe, A., Bochicchio, B., et al. (2024) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2024.118630 · Cited by 8
Approaching the Asymptote: Obstacles and Opportunities for Nanomedicine in Cardiovascular Disease
Goonewardena, S. N. (2012) · Current Atherosclerosis Reports · doi:10.1007/s11883-012-0249-9 · Cited by 7
Monocytic Cell Adhesion to Oxidised Ligands: Relevance to Cardiovascular Disease
Poston, R. N., Chughtai, J., Ujkaj, D., Louis, H., Leake, D. S., & Cooper, D. (2022) · Biomedicines · doi:10.3390/biomedicines10123083 · Cited by 5
Pathogenesis of the Plaque Vulnerability in Diabetes Mellitus
Rai, V., & Agrawal, D. K. (2017) · Springer eBooks · doi:10.1007/978-3-319-60324-7_4 · Cited by 5
Role of Oxidative Stress and Cardiovascular Risk Factors in Ischemic Heart Disease
Barteková, M., Ferenczyová, K., Jelemenský, M., & Dhalla, N. S. (2019) · Springer eBooks · doi:10.1007/978-981-13-8273-4_16 · Cited by 7
Factors affecting proteoglycan synthesis and structure that modify the interaction with lipoproteins
Yang, S. N. Y., Osman, N., Burch, M. L., & Little, P. J. (2009) · Clinical Lipidology · doi:10.2217/clp.09.37 · Cited by 5
Chen, Z., Fitzgerald, R. L., Saffitz, J. E., Semenkovich, C. F., & Schonfeld, G. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000062701.02853.ae · Cited by 6
Pathogenesis of Stable and Acute Coronary Syndromes
Bentzon, J. F., & Falk, E. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-4927-2.00006-2 · Cited by 9
Nanoparticles for Cardiovascular Imaging with CT
Chhour, P., Cheheltani, R., Naha, P. C., Litt, H. I., Ferrari, V. A., & Cormode, D. P. (2016) · Springer eBooks · doi:10.1007/978-3-319-42169-8_17 · Cited by 5
Vaverková, H. (2011) · Clinical Lipidology · doi:10.2217/clp.10.75 · Cited by 5
Williams, K. J., & Fisher, E. A. A. (2015) · Wiley eBooks · doi:10.1002/9781118828533.ch24 · Cited by 6
Complement C1q and von Willebrand factor interaction in atherosclerosis of human carotid artery
Schulz, K., Donat, C., Punjabi, M., Glatz, K., Kaufmann, B. A., & Trendelenburg, M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1265387 · Cited by 4
Larsen, J. H., Hegelund, J. S., Pedersen, M. K., Andersson, C. M., Lindegaard, C. A., Hansen, D. R., Stubbe, J., Lindholt, J. S., Hansen, C. S., Grentzmann, A., et al. (2024) · Cardiovascular Research · doi:10.1093/cvr/cvae174 · Cited by 5
“…charged due to sulfate and carboxylic acid groups in their glycosaminoglycan side chains and entrap LDL in the vessel wall by electrostatically interacting with stretches of positively charged residues on APOB100, as experimentally demonstrated for biglycan 55 and heparan-sulfate proteoglycan 2.”
Li, P., Sun, C., Yan, X., Xuan, Y., Xu, J., Wang, F., Weng, J., Li, Y., & Sun, K. (2024) · Korean Circulation Journal · doi:10.4070/kcj.2024.0153 · Cited by 4
Metadata
- Authors
- Skålén, K., Gustafsson, M., Rydberg, E. K., Hultén, L. M., Wiklund, O., Innerarity, T. L., & Borén, J.
- Affiliations
- University of Gothenburg (SE)
- Gladstone Institutes (US)
- Corresponding author
- Borén, Jan
- Venue
- Nature
- Published
- 2002-06
- Volume
- 417
- Issue
- 6890
- Pages
- 750-754
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2083154566
- Cited by
- 1,019
- References
- 28
- Citations by year
- 2026: 23 · 2025: 28 · 2024: 38 · 2023: 42 · 2022: 41 · 2021: 69 · 2020: 48 · 2019: 39 · 2018: 39 · 2017: 29 · 2016: 27 · 2015: 46 · 2014: 42 · 2013: 42 · 2012: 63
- FWCI
- 13.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- American Heart Association
- Research to Prevent Blindness
- Vetenskapsrådet
- National Institutes of Health
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- atherosclerosis, atherogenesis, apolipoprotein B, apolipoprotein B-100, low-density lipoprotein, proteoglycans, extracellular matrix, sulfate groups, transgenic mice, atherogenic lipoproteins
- MeSH terms
- Animals, Aorta, Apolipoproteins B, Arteriosclerosis, Binding, Competitive, Cholesterol, Diet, Atherogenic, Endothelium, Vascular, Female, Humans, Lipoproteins, Lipoproteins, LDL, Macrophages, Mice, Transgenic, Models, Biological, Mutation, Receptors, LDL, Recombinant Proteins, Triglycerides, Tumor Necrosis Factor-alpha, Amino Acid Substitution, Mice, Apolipoprotein B-100
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.